CAMBRIDGE, MA, Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, has successfully secured a $110 million Series E financing. more...
MENLO PARK, CA, AttoTude, the pioneer of groundbreaking THz interconnect technology for AI and hyperscale data center applications, today announced it has raised $50 million in Series B funding. more...